2011 Volume No 22  pages 275-290
|  Title: Transplantation of scaffold-free spheroids composed of synovium-derived cells and chondrocytes for the treatment of cartilage defects of the knee  | 
| Author: J-I Lee, M Sato, H-W Kim, J Mochida | 
|  Address: Department of Orthopaedic Surgery, Surgical Science, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193 Japan
                     | 
| E-mail: sato-m at is.icc.u-tokai.ac.jp | 
|  Key Words: Articular cartilage regeneration, injectable scaffold-free spheroids, high density suspension shaking culture method, synovium-derived cells, chondrocytes. | 
| Publication date: November 9th 2011 | 
|  Abstract: Autologous chondrocyte  implantation (ACI) is the treatment of choice for osteoarthritis. However, to regenerate  articular cartilage using this  method, the procedure paradoxically demands that the cell  source of the articular  chondrocytes (ACs) for ex vivo expansion be from  the patient’s own healthy cartilage, which can result in donor  site morbidity. Accordingly,  it is essential to develop a substitute for AC. In the present study, we investigated whether synovium-derived cells (SYs)  could be used as a partial replacement for ACs in ACI. ACs and SYs from the knees of rabbits were isolated and  cultured, and the growth rates of the cells were compared. To manufacture the cellular transplants, we  developed a high-density suspension-shaking culture method (HDSS), which  circulates the cells in culture media, promoting self-assembly of scaffold-free  cellular aggregates. ACs and SYs were mixed in various ratios using HDSS.  Injectable cellular transplants were harvested and transplanted into full-thickness osteochondral  defects. Simultaneously, histological evaluations were conducted with toluidine blue and safranin O, and  immunohistochemistry of collagen type I and II was conducted. Gene expression to evaluate  chondrocyte-specific differentiation was also performed. We successfully  prepared a large quantity of spheroids (spheroidal cell aggregates) in a short time using mixed ACs and SYs, for all cellular composition  ratios. Our data showed that the  minimal therapeutic unit for the transplants contributed to in situ regeneration of cartilage. In  summary, SYs can  be used as a replacement for ACs in clinical cases of ACI in patients with broad areas  of osteoarthritic lesions. | 
| Article download: Pages 
                275-290 (PDF file) | 

 
     
     
     
    